Fecal transplant to improve diabetes after weight loss surgery
Part of Hormones & metabolism clinical trials.
This trial tests whether transferring healthy stool bacteria from a lean donor can help improve blood sugar control in people with type 2 diabetes who still have high blood sugar 1-5 years after weight loss surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have type 2 diabetes and had weight loss surgery (gastric bypass or sleeve) 1 to 5 years ago
- Before surgery, your BMI was 35 or higher
- One year after surgery, your blood sugar is still high (HbA1c above 6.5% or fasting sugar above 6.9 mmol/L) or you need diabetes medication
- You are willing to take a stomach acid reducer (proton pump inhibitor) during the study
- You attended at least 2 of the 3 routine follow-up visits in your first year after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut hormones and blood sugar control change after Roux-en-Y gastric bypass. It may help researchers understand what supports healthier glucose levels after bariatric surgery.
This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.
This study tests a combination of a fecal microbiota transplant (FMT), a calorie-restricted diet, and a type 2 diabetes medication (semaglutide) for people with obesity and recently diagnosed type 2 diabetes. The goal is to see if this approach can improve blood sugar control and weight loss.
This study tests whether transferring healthy stool bacteria into your gut (called fecal microbiota transplantation) can help improve blood sugar control and heart health in people with type 2 diabetes and heart disease. It is a small, early-stage study to see if the treatment is safe and well-tolerated.
This trial tests whether transplanting specially cleaned gut bacteria from healthy donors can improve stomach and bowel symptoms in people with type 2 diabetes. It aims to see if this treatment is safe and effective for diabetic gastrointestinal motility disorders.
This study tests if taking capsules with processed donor stool can help preserve insulin-making cells in people recently diagnosed with type 1 diabetes. The treatment aims to slow the loss of insulin production.
Hear when a new Bariatric Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.